<VariationArchive VariationID="511" VariationName="NM_000037.4(ANK1):c.1519dup (p.Leu507fs)" VariationType="Duplication" Accession="VCV000000511" Version="5" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-05-27" DateCreated="2017-12-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15550" VariationID="511">
      <GeneList>
        <Gene Symbol="ANK1" FullName="ankyrin 1" GeneID="286" HGNC_ID="HGNC:492" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="41653225" stop="41896741" display_start="41653225" display_stop="41896741" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="41510743" stop="41754279" display_start="41510743" display_stop="41754279" Strand="-" />
          </Location>
          <OMIM>612641</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000037.4(ANK1):c.1519dup (p.Leu507fs)</Name>
      <CanonicalSPDI>NC_000008.11:41715734:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="41715734" stop="41715735" display_start="41715734" display_stop="41715735" variantLength="1" positionVCF="41715734" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="41573252" stop="41573253" display_start="41573252" display_stop="41573253" variantLength="1" positionVCF="41573252" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <OtherNameList>
        <Name>ankyrin Florian√≥polis</Name>
      </OtherNameList>
      <ProteinChange>L507fs</ProteinChange>
      <ProteinChange>L540fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="NP_000028.3" sequenceAccession="NP_000028" sequenceVersion="3" change="p.Leu507Profs*7">
            <Expression>NP_000028.3:p.Leu507Profs*7</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.41573258dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.41573258dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.41715740dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.41715740dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012820.2" sequenceAccession="NG_012820" sequenceVersion="2" change="g.186028dup">
            <Expression>NG_012820.2:g.186028dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000037.4" sequenceAccession="NM_000037" sequenceVersion="4" change="c.1519dup" MANESelect="true">
            <Expression>NM_000037.4:c.1519dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000028.3" sequenceAccession="NP_000028" sequenceVersion="3" change="p.Leu507fs">
            <Expression>NP_000028.3:p.Leu507fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142446.2" sequenceAccession="NM_001142446" sequenceVersion="2" change="c.1618dup">
            <Expression>NM_001142446.2:c.1618dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135918.1" sequenceAccession="NP_001135918" sequenceVersion="1" change="p.Leu540fs">
            <Expression>NP_001135918.1:p.Leu540fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020475.3" sequenceAccession="NM_020475" sequenceVersion="3" change="c.1519dup">
            <Expression>NM_020475.3:c.1519dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065208.2" sequenceAccession="NP_065208" sequenceVersion="2" change="p.Leu507fs">
            <Expression>NP_065208.2:p.Leu507fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020476.3" sequenceAccession="NM_020476" sequenceVersion="3" change="c.1519dup">
            <Expression>NM_020476.3:c.1519dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065209.2" sequenceAccession="NP_065209" sequenceVersion="2" change="p.Leu507fs">
            <Expression>NP_065209.2:p.Leu507fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020477.3" sequenceAccession="NM_020477" sequenceVersion="3" change="c.1519dup">
            <Expression>NM_020477.3:c.1519dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065210.2" sequenceAccession="NP_065210" sequenceVersion="2" change="p.Leu507fs">
            <Expression>NP_065210.2:p.Leu507fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142446.2" sequenceAccession="NM_001142446" sequenceVersion="2" change="c.1618dupC">
            <Expression>NM_001142446.2:c.1618dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020476.2" sequenceAccession="NM_020476" sequenceVersion="2" change="c.1519dupC">
            <Expression>NM_020476.2:c.1519dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA114345" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="612641.0005" DB="OMIM" />
        <XRef Type="rs" ID="397514029" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000037.4(ANK1):c.1519dup (p.Leu507fs) AND Hereditary spherocytosis type 1" Accession="RCV000000540" Version="8">
        <ClassifiedConditionList TraitSetID="11733">
          <ClassifiedCondition DB="MedGen" ID="C2674218">Hereditary spherocytosis type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-09" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000037.4(ANK1):c.1519dup (p.Leu507fs) AND ANK1-related disorder" Accession="RCV003415605" Version="4">
        <ClassifiedConditionList TraitSetID="89348">
          <ClassifiedCondition>ANK1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-09" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-12-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11167760</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="89348" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69376" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANK1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ANK1-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="11733" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4170" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spherocytosis type 1</ElementValue>
                <XRef ID="MONDO:0008447" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spherocytosis type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANK1-Related Spherocytosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HS1</ElementValue>
                <XRef Type="MIM" ID="182900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SPH1</ElementValue>
                <XRef Type="MIM" ID="182900" DB="OMIM" />
              </Symbol>
              <XRef ID="822" DB="Orphanet" />
              <XRef ID="C2674218" DB="MedGen" />
              <XRef ID="MONDO:0008447" DB="MONDO" />
              <XRef Type="MIM" ID="182900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20689" SubmissionDate="2017-12-11" DateLastUpdated="2017-12-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612641.0005_SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN FLORIANOPOLIS" title="ANK1, 1-BP INS, 506C_SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN FLORIANOPOLIS" />
        <ClinVarAccession Accession="SCV000020689" DateUpdated="2017-12-15" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated probands from different ethnic backgrounds who had severe hereditary spherocytosis (SPH1; 182900) requiring splenectomy, Gallagher et al. (2000) found the same frameshift mutation in exon 4, insertion of an extra cytosine nucleotide at codon 506 of the ANK1 gene. The patients were of Italian, Portuguese, and German extraction and the mutation was on a different haplotype in each.</Attribute>
              <Citation>
                <ID Source="PubMed">11167760</ID>
              </Citation>
              <XRef DB="OMIM" ID="182900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANK1" />
          </GeneList>
          <Name>ANK1, 1-BP INS, 506C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 506C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612641.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN FLORIANOPOLIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7700085" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="3564008|ANK1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004113050" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ANK1 c.1519dupC variant is predicted to result in a frameshift and premature protein termination (p.Leu507Profs*7). This variant has previously been reported to be causative for autosomal dominant hereditary spherocytosis (Gallagher et al 2000. PubMed ID: 11167760; Aggarwal A et al 2019. PubMed ID: 31602632; Tole S et al 2020. PubMed ID: 32436265;). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in ANK1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANK1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020476.2:c.1519dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANK1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7913295" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="b56bc8f8d24cc5946089911e2557be588c09b9aaede806b354217151edba6050|OMIM:182900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004236919" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000037.4:c.1519dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="182900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3597498" SubmissionDate="2021-09-04" DateLastUpdated="2021-09-12" DateCreated="2021-09-12">
        <ClinVarSubmissionID localKey="20025|OMIM:182900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001837623" DateUpdated="2021-09-12" DateCreated="2021-09-12" Type="SCV" Version="1" SubmitterName="Suma Genomics" OrgID="508066" OrganizationCategory="laboratory" OrgAbbreviation="Suma" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next Generation Sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANK1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001142446.2:c.1618dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="182900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10319532</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8352561" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="3680840|OMIM:182900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004565003" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ANK1 c.1519dup; p.Leu507ProfsTer7 variant (rs397514029) is reported in the literature in at least five individuals affected with hereditary spherocytosis (Aggarwal 2020, Gallagher 2000, Tole 2020). This variant is also reported in ClinVar (Variation ID: 511). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. REFERENCES Aggarwal A et al. Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study. Br J Haematol. 2020 Mar. PMID: 31602632 Gallagher PG et al. A recurrent frameshift mutation of the ankyrin gene associated with severe hereditary spherocytosis. Br J Haematol. 2000 Dec. PMID: 11167760 Tole S et al. Genotype-phenotype correlation in children with hereditary spherocytosis. Br J Haematol. 2020 Nov. PMID: 32436265</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANK1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.41573258dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="182900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7700085" TraitType="Disease" MappingType="Name" MappingValue="ANK1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="ANK1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20689" TraitType="Disease" MappingType="Name" MappingValue="SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN FLORIANOPOLIS" MappingRef="Preferred">
        <MedGen CUI="C2674218" Name="Hereditary spherocytosis type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3597498" TraitType="Disease" MappingType="XRef" MappingValue="182900" MappingRef="OMIM">
        <MedGen CUI="C2674218" Name="Hereditary spherocytosis type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8352561" TraitType="Disease" MappingType="XRef" MappingValue="182900" MappingRef="OMIM">
        <MedGen CUI="C2674218" Name="Hereditary spherocytosis type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7913295" TraitType="Disease" MappingType="XRef" MappingValue="182900" MappingRef="OMIM">
        <MedGen CUI="C2674218" Name="Hereditary spherocytosis type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

